OXY Rapid Test Kit For Urine Sample DOA Diagnostic Test Cassette
OXY Rapid Test is a rapid, screening test for the qualitative detection of OXY and metabolites in human urine at specified cut off levels.
For professional use only.
For in vitro diagnostic use only.
【INTENDED USE】
OXY Rapid Test is an immuno-chromatographic assay for the qualitative determination of the presence of OXY listed in the table below.
Drug(Identifier) |
Calibrator |
Cut-off level |
OXY
|
OXY
|
300 ng/mL
|
This assay provides only a preliminary analytical test result. Gas Chromatography/Mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to OXY of abuse test result, particularly when preliminary positive results are indicated.
【SUMMARY】
OXY is an analgesic, which works by depressing the central nervous system. OXY is abused for its opiate-like effects. In addition to its equal potency to MOP in analgesic effects, it is also equipotent to MOP in relieving abstinence symptoms from chronic opiate use. For this reason, it is often used to alleviate or prevent the onset of opiate withdrawal by street users of MET. The drug is most often administered orally. Like other opiates, OXY can also depress the respiratory system resulting in suffocation and death when overdosed. OXY is very addictive, both physically and psychologically. Some physical indications of OXY abuse include extreme loss of appetite and weight, cramps, nausea, vomiting, excessive scratching and complaint of itching, excessive sweating, constipation, pin-point pupils and watery eyes, reduced vision, drowsiness, euphoria, trance-like states, excessive thirst, tremors, twitching, irritability, hallucinations and lethargy.
【PRINCIPLE】
OXY Rapid Test is a competitive immunoassay that is used to screen for the presence of OXY and metabolites in urine. It is chromatographic absorbent device in which, drugs within a urine sample, competitively combined to a limited number of drug monoclonal antibody (mouse) conjugate binding sites.
When the test is activated, the urine is absorbed into test by capillary action, mixes with the respective drug monoclonal antibody conjugate, and flows across a precoated membrane. When drug within the urine sample is below the detection level of the test, respective drug monoclonal antibody conjugate binds to the respective drug-protein conjugate immobilized in the Test Region (T) of the test . This produces a colored Test line in the Test Region (T) of the Test, which, regardless of its intensity, indicates a negative test result.
When sample drug levels are at or above the detection level of the test, the free drug in the sample binds to the respective drug monoclonal antibody conjugate, preventing the respective drug monoclonal antibody conjugate from binding to the respective drug-protein conjugate immobilized in the Test Region (T) of the device. This prevents the development of a distinct colored band in the test region, indicating a preliminary positive result.
To serve as a procedure control, a colored line will appear at the Control Region (C) of Test, if the test has been performed properly.
【WARNINGS AND PRECAUTIONS】
• Immunoassay for in vitro diagnostic use only.
• Do not use after expiration date.
• The test should remain in the sealed pouch until use.
• The used test should be discarded according to local regulations.
【CONTENTS】
• Drug Test.
• Desiccant
• Leaflet with instruction for use.
【STORAGE AND STABILITY】
• The kit should be stored at 2-30°C until the expiry date printed on the sealed pouch.
• The test must remain in the sealed pouch until use.
• Keep away from direct sunlight, moisture and heat.
• Do not freeze.
• Care should be taken to protect the components of the kit from contamination. Do not use if there is evidence of microbial contamination or precipitation. Biological contamination of dispensing equipment, containers or reagents can lead to false results.
【OPERATION】
Test must be in room temperature (15ºC to 30ºC)
1. Donor collects urine specimen in a urine cup.
2. Cassette and Strip Operation:
2.1 Cassette:
Remove test device/cassette from the sealed pouch.
Lay the cassette flat, add 2 drops of urine specimen by sample dropper into the sample well.
2.2 Distick Panel or Strip:
Remove test strip from the sealed pouch.
Dip the arrowed end of the test strip into the container with urine sample, take it out in 10 seconds and lay flat.
3. The result should be read at 5 minutes. Do not interpret the result after 10 minutes.
【INTERPRETATION OF RESULTS】
Preliminary positive (+)
Only one colored band appears, in the control region (C). No colored band appears in the test region (T).
Negative (-)
Two colored bands appear on the membrane. One band appears in the control region (C) and another band appears in the test region (T).
Invalid
Control band fails to appear. Results from any test which has not produced a control band at the specified read time must be discarded. Please review the procedure and repeat with a new test. If the problem persists, discontinue using the kit immediately and contact your local distributor.

Cassette/Device
For further operation or performance details, please refer to final instruction manual.